Aeris Therapeutics

Woburn, United States Founded: 2000 • Age: 26 yrs Acquired By Pulmonx
Products for treating emphysema and lung diseases are developed.
Request Access

About Aeris Therapeutics

Aeris Therapeutics is a company based in Woburn (United States) founded in 2000 was acquired by Pulmonx in January 2015.. Aeris Therapeutics operates in a competitive market with competitors including Pulmonx, Neurent Medical, Gradient Denervation Technologies, Spiration and Uptake Medical, among others.

  • Headquarter Woburn, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $391.78 K (USD), Grant

    Apr 08, 2009

  • Investors
    Pulmonx

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Pulmonx

    (Jan 08, 2015)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Aeris Therapeutics

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $391,775
  • First Round

    (20 Sep 2004)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2009 Amount Grant - Aeris Therapeutics Valuation

investors

HHS
Apr, 2007 Amount Grant - Aeris Therapeutics Valuation

investors

HHS
Sep, 2004 Amount Grant - Aeris Therapeutics Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Aeris Therapeutics

Aeris Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Pulmonx and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Developer of smart devices for treating pulmonary diseases
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Aeris Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Aeris Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aeris Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aeris Therapeutics

Aeris Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pulmonx, Neurent Medical, Gradient Denervation Technologies, Spiration and Uptake Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of smart devices for treating pulmonary diseases
domain founded_year HQ Location
Smart devices for minimally invasive rhinitis treatment are developed.
domain founded_year HQ Location
Endovascular catheter-based technology for pulmonary hypertension treatment is provided.
domain founded_year HQ Location
IntraBronchial Valve to treat lung disease
domain founded_year HQ Location
Targeted vapor therapy is developed for endoscopic lung volume reduction.
domain founded_year HQ Location
Endobronchial valves for emphysema treatment are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aeris Therapeutics

Frequently Asked Questions about Aeris Therapeutics

When was Aeris Therapeutics founded?

Aeris Therapeutics was founded in 2000 and raised its 1st funding round 4 years after it was founded.

Where is Aeris Therapeutics located?

Aeris Therapeutics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.

What does Aeris Therapeutics do?

Aeris Therapeutics was founded in 2000 and is based in Woburn, United States. Focus is placed on medical devices within the pulmonology sector. The AeriSeal System is provided to decrease lung volume and enhance function for individuals with severe emphysema. Damaged lung regions are addressed through bronchoscope-based procedures. Operations center on advancing treatments for emphysema and related respiratory conditions.

Who are the top competitors of Aeris Therapeutics?

Aeris Therapeutics's top competitors include Pulmonx, Neurent Medical and Gradient Denervation Technologies.

Who are Aeris Therapeutics's investors?

Aeris Therapeutics has 2 investors. Key investors include Pulmonx, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available